Trial Profile
Tetravalent dengue vaccine trial
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 11 Jan 2010
Price :
$35
*
At a glance
- Drugs Dengue vaccine (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Hawaii Biotech
- 11 Jan 2010 Hawaii Biotech plans to initiate clinical development later in 2010, according to a company media release.
- 11 Jan 2010 New trial record.